Intravenous Infusion Pump Market Size & Outlook, 2026-2034

Intravenous Infusion Pump Market Overview

The global intravenous infusion pump market size was valued at USD 6.24 billion in 2025 and is estimated to grow from USD 6.77 billion in 2026 to reach USD 13.38 billion by 2034, growing at a CAGR of 8.87% during the forecast period (2026–2034). The market is driven by the rising prevalence of chronic diseases, increasing demand for homecare and critical care infusion therapies, and growing adoption of smart, automated pumps that enhance patient safety, dosing accuracy, and clinical workflow efficiency.

Key Market Trends & Insights

• North America held the largest market share, over 50% of the global market.
• By Product, the volumetric infusion segment held the highest market share of over 15%.
• By Disease Indication, the chemotherapy segment is expected to witness the fastest CAGR of 9.57%.

Market Size & Forecast

• 2025 Market Size: USD 6.24 billion
• 2034 Projected Market Size: USD 13.38 billion
• CAGR (2025-2033): 8.87%
• North America: Largest market in 2024

An intravenous infusion pump is a medical device designed to deliver fluids, medications, or nutrients directly into a patient’s bloodstream with precise control over rate and volume. Widely used in hospitals, outpatient facilities, and homecare settings, these pumps support applications such as chemotherapy, insulin therapy, pain management, anesthesia, and pediatric care. By enabling accurate, continuous, and controlled drug delivery, infusion pumps enhance treatment effectiveness, reduce human error, and improve patient safety across a wide range of clinical scenarios.

The market is supported by increasing demand for pediatric and neonatal care devices, rising adoption of advanced infusion systems in critical care, and government initiatives promoting patient safety. Opportunities exist in developing countries with expanding healthcare infrastructure, growing homecare services, and integration of automation and connectivity technologies. Moreover, manufacturers are investing in R&D to create innovative solutions for oncology, analgesia, and chronic disease management, enhancing workflow efficiency and improving clinical outcomes globally.

Latest Market Trend

Rising demand for ambulatory and portable infusion pumps

The global intravenous infusion pump market is witnessing growing demand for ambulatory and portable devices, driven by the shift toward home healthcare and outpatient care models. Patients increasingly prefer compact and easy-to-use systems that enable continuous treatment outside hospitals, supporting independence, comfort, and adherence to prescribed therapies.

This trend is further reinforced by rising cases of chronic illnesses, where long-term drug administration is essential. Portable infusion pumps are proving vital in oncology, pain management, and diabetes care, offering flexibility without compromising safety. Their adoption highlights the healthcare industry’s focus on patient-centered solutions and technology-driven convenience.

To get more insights about this report Download Free Sample Report

Market Driver

Rising prevalence of chronic illnesses

The global intravenous infusion pump market is being driven by the rising prevalence of chronic illnesses, which are placing an increasing demand on continuous and precise medication delivery. Patients with conditions such as diabetes and cardiovascular diseases require long-term infusion therapies, both in hospitals and home care settings.

• For instance, the International Diabetes Federation (IDF) reports that 589 million adults (20–79 years) are living with diabetes worldwide, representing 11.1% of the adult population, with projections reaching 853 million by 2050.
• Similarly, cardiovascular diseases are expected to increase by 90% in prevalence and 73.4% in mortality between 2025 and 2050.

This growing burden of chronic diseases is encouraging healthcare providers to adopt advanced infusion pumps that ensure safety, accuracy, and convenience for patients.

Market Restraint

Frequent reports of device recalls and malfunctions

The global intravenous infusion pump market faces challenges due to frequent reports of device recalls and malfunctions. Such issues raise concerns about patient safety and reliability, leading to cautious adoption among healthcare providers. Malfunctions can result from software glitches, hardware failures, or improper usage, prompting regulatory scrutiny and increased compliance requirements. These incidents not only affect manufacturer credibility but also slow market growth, as hospitals and clinics prioritize proven, safe devices over newer, untested models. Addressing these risks is critical for sustaining trust and adoption.

Market Opportunity

Advancing smart pumps through IoT, AI & EHR integration

The global intravenous infusion pump market presents significant opportunities with the advancement of smart pumps through IoT, AI, and EHR integration. Healthcare providers are increasingly seeking automated and connected systems that improve workflow efficiency, reduce human error, and enhance patient safety.

• For instance, in June 2025, MEDITECH introduced a bidirectional integration between its Expanse EHR and smart infusion pumps, enabling seamless data exchange where infusion orders are sent directly to the pump, and infusion data, such as start/stop times and rates, are transmitted back to the EHR.
• Similarly, in May 2025, Penlon launched the HP TCi Syringe Pump, designed for critical care intravenous anesthesia, featuring a touchscreen interface, AI-assisted dose calculations, and real-time monitoring.

These innovations highlight the market’s focus on technology-driven, patient-centered solutions that optimize clinical outcomes.

Regional Analysis

North America remains the dominant region in the global intravenous infusion pump market due to the presence of advanced healthcare infrastructure, increasing hospital admissions, and a high prevalence of chronic diseases. The region benefits from rapid adoption of technologically advanced infusion systems, such as smart pumps integrated with IoT and AI, and strong regulatory frameworks ensuring device safety. Moreover, leading medical device companies actively invest in R&D to enhance product accuracy, efficiency, and connectivity, further driving the demand for reliable and sophisticated infusion solutions across hospitals, homecare, and critical care settings.

• The United States intravenous infusion pump market is characterized by high adoption of advanced infusion pumps, particularly volumetric and smart systems. Key players such as ICU Medical, Baxter International, and Becton Dickinson are leading product launches and innovations in AI-enabled and EHR-integrated pumps. Rising cases of diabetes, cardiovascular diseases, and oncology treatments are driving demand for precise medication delivery.
• Canada’s market is growing steadily, supported by increasing healthcare expenditures and the modernization of hospital facilities. Companies like Smiths Medical, Baxter International, and B. Braun are actively providing volumetric and syringe infusion pumps with advanced safety and monitoring features. Chronic disease prevalence and an aging population contribute to the rising demand for continuous and precise drug administration.

Asia-Pacific: Significantly Growing Region

Asia-Pacific is emerging as a rapidly growing region due to expanding healthcare infrastructure, rising chronic disease prevalence, and increasing hospital admissions. The adoption of advanced infusion systems, including smart pumps with AI and IoT integration, is accelerating in leading healthcare centers. The market is further boosted by the growth of homecare services, increasing disposable incomes, and government initiatives aimed at improving patient safety and clinical outcomes. Investments by global manufacturers and rising awareness among healthcare providers about technologically advanced infusion therapies make Asia-Pacific one of the fastest-growing regions globally.

• China’s intravenous infusion pump market is growing rapidly, fueled by expanding hospital networks, urban healthcare infrastructure, and rising chronic disease cases. Leading companies such as Mindray, B. Braun, and Baxter provide advanced volumetric and syringe infusion pumps, often integrated with smart monitoring systems. The market is further supported by government policies promoting modern healthcare technology and patient safety.
• India’s market is expanding due to rising hospital infrastructure, increasing outpatient care, and growing prevalence of chronic and critical illnesses. Companies like B. Braun, Fresenius Kabi, and Mindray offer technologically advanced pumps, including portable, smart, and pediatric-focused devices. Moreover, government initiatives and healthcare modernization projects encourage the adoption of automated infusion systems.

Product Insights

Volumetric infusion pumps dominate the market due to their high precision in delivering large fluid volumes over extended periods. Widely used in hospitals and critical care units, they ensure accurate medication and fluid administration, reducing the risk of errors. These pumps are compatible with multiple therapy types, including hydration, antibiotics, and parenteral nutrition. Their reliability, ease of use, and integration with hospital systems make them a preferred choice for healthcare providers managing diverse patient populations.

Disease Indication Insights

The pediatrics and neonatology segment leads the disease indication category, reflecting the critical need for precise and safe medication delivery in infants and young children. These patients require carefully controlled infusion rates to avoid complications, particularly in neonatal intensive care units. Advanced infusion pumps designed for pediatric use provide accurate dosing, minimize errors, and enhance safety, making them indispensable in managing treatments such as nutrition, antibiotics, and pain management for vulnerable patients.

Company Market Share

In the global market, companies are focusing on advancing smart infusion technologies that improve dosing accuracy and patient safety. Efforts are directed toward integrating wireless connectivity, AI-based monitoring, and automated alerts to enhance clinical workflow efficiency. Manufacturers are also developing portable and compact devices suitable for home healthcare, alongside robust software solutions for real-time data tracking. Moreover, there is a strong emphasis on compliance with regulatory standards and designing pumps that reduce medication errors while supporting diverse healthcare settings.

Baxter

Baxter International, established in 1931 in Chicago, is a leading player in the intravenous infusion pump market. The company focuses on developing advanced infusion systems that enhance patient safety and dosing accuracy. Baxter emphasizes smart pump technologies with integrated safety features and connectivity solutions for hospitals and home care. Its ongoing innovations target workflow efficiency, real-time monitoring, and compliance with global regulatory standards, reinforcing its strong presence.

• In September 2025, Baxter International Inc. introduced the Welch Allyn Connex 360 Vital Signs Monitor, a patient monitoring device designed to enhance clinical workflows and patient care. This next-generation monitor captures a comprehensive set of vital signs—including blood pressure, temperature, pulse rate, respiration rate, and blood oxygen levels—for adult, pediatric, and neonatal patients in under one minute.

List of key players in Intravenous Infusion Pump Market

1. Baxter
2. Braun Medical Inc.
3. Medtronic
4. Micrel Medical Devices SA
5. Boston Scientific Corporation
6. Cardinal Health
7. Fresenius Kabi AG
8. ICU Medical, Inc.
9. Hoffmann-La Roche Ltd
10. Tandem Diabetes Care, Inc.
11. Terumo Corporation
12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13. Moog Inc.
14. IRadimed Corporation

To get more findings about this report Download Market Share

Recent Development

• March 2025 - Tandem Diabetes Care has launched its new Control-IQ+ automated insulin delivery technology, now available for individuals aged 2 and older with type 1 diabetes, as well as adults with type 2 diabetes. This advancement enhances insulin delivery precision and expands access to automated diabetes management.